Luke Stacey

Luke Stacey has accumulated a diverse and extensive background in the clinical research field, having held various managerial and monitoring roles in different companies such as BeiGene, PSI CRO AG, PPD, and more. With a solid educational foundation in Molecular Biotechnology and Pharmacology from the University of Sydney, Luke has demonstrated a strong ability to oversee the execution of project deliverables, manage clinical resources, track and distribute metric updates, and ensure regulatory compliance in clinical trials. Luke has consistently shown leadership and expertise in handling multiple therapeutic areas and ensuring studies are completed on time and within budget.